| Entry |
|
|---|
| Name |
Talsaclidine fumarate (USAN) |
|---|
| Formula |
C10H15NO. C4H4O4
|
|---|
| Exact mass |
281.1263
|
|---|
| Mol weight |
281.30
|
|---|
| Structure |
|
|---|
| Class |
Neuropsychiatric agent
DG01490 Muscarinic cholinergic receptor agonist
|
|---|
| Efficacy |
Dementia therapeutic agent, Muscarinic acetylcholine receptor M1 agonist |
|---|
| Comment |
Alzheimer's disease treatment
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Interaction |
|
|---|
| Structure map |
| map07220 | Cholinergic and anticholinergic drugs |
|
|---|
| Brite |
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01490 Muscarinic cholinergic receptor agonist
D06000 Talsaclidine fumarate
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Acetylcholine (muscarinic)
CHRM1
D06000 Talsaclidine fumarate (USAN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 20
1 C6a C 22.3164 -15.3838
2 C2b C 23.5334 -16.0891
3 O6a O 21.0997 -16.0891
4 O6a O 22.3164 -13.9790
5 C2b C 24.7558 -15.3838
6 C6a C 25.9726 -16.0891
7 O6a O 27.1894 -15.3838
8 O6a O 25.9726 -17.4939
9 C1x C 10.8055 -18.4124
10 N1y N 12.2828 -17.5682
11 C1x C 10.1020 -17.4275
12 C1x C 12.2828 -16.3019
13 C1x C 13.7602 -18.3420
14 C1y C 11.5090 -16.5833
15 C1x C 11.5090 -15.5984
16 C1y C 13.0567 -17.2868
17 O2a O 13.9681 -16.2150
18 C1b C 15.3580 -16.4694
19 C3b C 16.2911 -15.3720
20 C3a C 17.2860 -14.3771
BOND 20
1 1 2 1
2 1 3 1
3 1 4 2
4 2 5 2
5 5 6 1
6 6 7 1
7 6 8 2
8 9 10 1
9 9 11 1
10 10 12 1
11 10 13 1
12 11 14 1
13 12 15 1
14 13 16 1
15 14 15 1
16 14 16 1
17 16 17 1 #Up
18 17 18 1
19 18 19 1
20 19 20 3
|
|---|
